Loading viewer...
investor_presentation
Format: PDF investor_presentation
SciSparc develops proprietary cannabinoid-based pharmaceutical treatments designed to increase patient safety by reducing required doses while maintaining therapeutic effectiveness. The company leverages platform technologies to advance its product pipeline through clinical trials and research initiatives.
investor_presentation
62 Pages
Allied
Volpara Health 2021 Breast Cancer AI Detection Prevention
investor_presentationinvestor_presentation
24 Pages
Volpara Health Technologies